Overview

Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
0
Participant gender:
All
Summary
Compare the efficiency of the association, first line, the intravenous levetiracetam and the intravenous clonazepam, in that of a monotherapy of clonazepam intravenous in the pre-hospital treatment of tonicoclonic generalised status epilepticus.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Anticonvulsants
Clonazepam
Etiracetam
Levetiracetam
Piracetam
Criteria
Inclusion criteria :

- Age ≥ 18 years

- Patient taken care by a prehospital medical team participating in the study

- Diagnosis of tonicoclonic generalized status epilepticus confirmed on the spot by a
physician of the team.

Exclusion criteria :

- Parent or the reliable person indicated by the patient present not giving its
agreement for the inclusion

- Pregnancy clinically detectable or known for close relations at the time of the status
epilepticus

- tonicoclonic generalized status epilepticus after anoxia post cardiac arrest

- Patient having already received another treatment for the same episode of status
epilepticus

- Patient having already participated in the study during a previous episode of status
epilepticus

- Patient in "latent" status epilepticus. Definition : patient in the coma having
epileptic demonstrations (CLONISMS MYOCLONISMS) small or invalid, contrasting with
permanent generalized electric seizures on the EEG

- Patient presenting certain diagnosis of pseudo name psychogenic seizure

- Patient whose neurological status requires an immediate surgery (traumatism)

- Patient having a hyper-responsiveness about the levetiracetam or about the other
by-products of pyrrolidone or an one of the excipients

- Patient having a hyper-responsiveness about the clonazepam, about the benzodiazepins
or about one of the other constituents of the product

- Patient under medical guardianship

- Not membership in a schema of medical assurance.